| Type 2 Diabetes Mellitus |
| Improves glycemic control |
| Used when monotherapy is insufficient |
Tablet
Sitagliptin IP 50 mg /500 mg & Metformin Hydrochloride Tablet is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. They help your pancreas produce more insulin, facilitate the effective use of insulin by the body, and reduce excess sugar that your liver makes. Together, they provide better control of blood sugar.
| Speciality | Anti-Diabetic | Endocrinology |
|---|---|
| Tags | DPP-4 Inhibitor | Oral Hypoglycemic |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.